Atlas Trials

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Clinical trial NCT00889486 · COMPLETED

Trial details

NCT number
NCT00889486
Sponsor
Tranzyme, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GastroparesisDiabetes Mellitus
Start date
2009-04-01
Primary completion
2010-04-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.